Qiagen and Roche settle DxS distribution dispute
This article was originally published in Clinica
Executive Summary
Diagnostics rivals Qiagen and Roche Molecular Systems have settled a legal disagreement over distribution rights for products sold by the former’s DxS subsidiary.